EW
Edwards Lifesciences Corporation
B
74.7 / 100 composite
AlphaQuality composite grade, weighted for stable earnings power businesses.
-
5yr Avg ROIC
16.5%
-
Operating Margin Trend
-1.39 pp/yr
-
5yr Avg ROE
25.0%
-
5yr Share-Count CAGR
-1.5%
-
5yr Revenue CAGR
6.7%
-
5yr EPS CAGR
7.1%
-
Revenue-Growth Years (5)
4/5
-
5yr FCF Margin
16.9%
-
5yr FCF/NI Conversion
0.66x
-
Net Debt / EBITDA
-2.46x
-
Interest Coverage (EBIT/Int)
30.00x
-
Altman Z-Score
11.40
Stability
Weight: 15%
D+
43
-
EPS Volatility (σ/μ)
0.85
-
Negative-Revenue Years (5)
1/5
-
Piotroski F-Score
6
3 of 4 gurus held; 1 added; 2 trimmed; 2 full exits.
- Holders
- 3
-1
- Avg Δ position
-
-28.5%
- New buys
- 0
- Full exits
- 2